Advanced Business Intelligence
for the Biopharma Industry

Get a Free Trial

BioCentury's BCIQ is unlike any other business intelligence and research tool on the market. It combines over 25 years of BioCentury's leading analysis of the biopharma industry with fully vetted and meticulously maintained data. Quite simply, BCIQ is the most accurate, in-depth tool for your research and business intelligence needs. Request a Free BCIQ Trial

Pinpoint New Licensing & Investment Opportunities

Whether you are a BD professional targeting new licensing opportunities or an investor pursuing your next financing move, BCIQ helps you assess prospects and make intelligent business decisions. Leverage BCIQ’s robust pipeline data to find unpartnered assets or conduct a deep-dive analysis of companies’ financials and products.

Request a Free BCIQ Trial

View Content-Rich Profile Reports

Quickly get an overview of a particular company, target, disease, product or deal. BCIQ’s redesigned profiles not only provide a vast amount of data, they also present it in a well-organized, graphical layout. Now you can easily see pipeline summaries, in- and out-licensed products, deal comps, financings and more on one, easy-to-scroll page.

Request a Free BCIQ Trial

Put Context Around the Data

While other databases just provide data, BCIQ goes a step further by putting thought-leading analysis around its data. A simple click displays all the content pertaining to a particular company, target, disease or product from BioCentury’s archive of more than 250,000 articles, charts and tables.

Request a Free BCIQ Trial

Discover Untapped Target Spaces

Redesigned filters combined with an expanded target database give you comprehensive tools to search for novel or untapped target spaces. With just a few clicks, you can build the competitive landscape for a particular target or target family. Quickly see which companies are in a particular target space and determine if it is overcrowded or presents white space opportunities.

Request a Free BCIQ Trial

Create Interactive Custom Charts & Reports

Effortlessly move from data to insight to action. Quickly generate custom charts and reports that are not only attractive, but dynamic and interactive as well. A simple click takes you on a deep dive into the data without having to leave your workspace. Drill down into a particular disease category or target space to discover unpartnered and partnered assets and opportunities.

Request a Free BCIQ Trial

The Right Decisions Start with the Right Data

Build Competitive Landscapes…Fast

Create complete competitive landscapes for products, companies and targets. View licensing status by indication and phase of development, and identify trending therapeutic modalities and targets in any disease area.

Stay In the Know with Custom Alerts & Notifications

Let BCIQ handle your competitive intelligence. Receive breaking news about competitors, updated information on products and targets and the latest thought-leading analysis from BioCentury’s editorial team.

Save Time with Fully Integrated Data Sets

BCIQ streamlines the steps required to prep and refine data by giving you the ability to structure queries across all data types and categories simultaneously, including target, product, deal, financial and geographic filters. Build complex queries, targeted company sets or peer groups on the spot.

Analyze Detailed Company Profiles

Robust company profiles provide a snapshot of a company’s pipeline, financings, deals and earnings. Take a deep dive into a company’s lead products by phase of development, future milestones, historical partnerships, individual investment rounds, investors and more.

Discover Emerging Companies

When new private companies want to get their stories out, they turn to BioCentury for coverage. Quickly and easily navigate to reports, articles and analysis on hundreds of these emerging companies.

Evaluate Key Financial Metrics of Deals

BCIQ puts the most important information about deals at your fingertips. Easily research M&A premiums and quickly view announced deal value, upfront payments, R&D funding, milestone payments and royalties.